Photothermal Depth Profiling of Gelatin-Stabilised Gold Nanorods-Trastuzumab Conjugate as a Potential Breast Cancer Photothermal Agent

Gold nanorods (AuNRs) are powerful photothermal agents (PTAs) in cancer treatment due to their near-infrared laser light absorption ability. However, the cytotoxicity of AuNRs caused by the presence of cationic surfactants often used and their lack of specificity affect their application in photothermal therapy. Thus, we herein developed a bioconjugate obtained from the functionalisation of AuNRs to gelatin (Gel@AuNRs), followed by the conjugation of the as-synthesised material to a breast cancer antibody, trastuzumab (Trast-Gel@AuNRs) to address these issues. The optical and structural characterization of the as-synthesized indicated no significant changes in the optical properties of AuNRs after their functionalisation with gelatin and conjugation with the antibody. The photothermal profiling of the as-synthesised materials showed that AuNRs still have an excellent photothermal conversion efficiency (PCE) after their functionalisation (20%) and their conjugation to an antibody (19%). In addition, the In vitro photothermal depth response showed that Trast-Gel@AuNRs is a promising photothermal agent for HER2-positive breast cancer treatment. Graphical Abstract: (Figure presented.)